QBManager

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347705 Match the following

Column I	Column II
A. Meloidogyne incognita	P. Controls corn borer
B. cryIAb	Q. Controls bollworm
C. cryIAc and cryIIAb	Q. Controls bollworm
D. ADA deficiency	R. Gene therapy
	S. Infects roots of tobacco plant

1 \({\text{A - Q,B - P,C - R,D - S}}\)

2 \({\text{A - S, B - P, C - Q, D - R}}\)

3 \({\text{A - P, B - R, C - S, D - Q}}\)

4 \({\text{A - S, B - Q, C - R, D - P}}\)

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347782 Early diagnosis of disease can be done by the technique

1 ELISA

2 PCR

3 Recombinant DNA technology

4 All the above

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347700 The first clinical gene therapy was done for the treatment of:

1 AIDS

2 Cancer

3 Cystic fibrosis

4 SCID (Severe Combined Immuno
Deficiency resulting from deficiency of ADA)

NCERTExemplar

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347699 The site of production of ADA in the body is

1 Blood plasma

2 Osteocytes

3 Lymphocytes

4 Erythrocytes

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347697 Assertion :
Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused.
Reason :
It affects the human digestive system.

1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.

2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.

3 Assertion is correct but Reason is incorrect.

4 Both Assertion and Reason are incorrect.

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347705 Match the following

Column I	Column II
A. Meloidogyne incognita	P. Controls corn borer
B. cryIAb	Q. Controls bollworm
C. cryIAc and cryIIAb	Q. Controls bollworm
D. ADA deficiency	R. Gene therapy
	S. Infects roots of tobacco plant

1 \({\text{A - Q,B - P,C - R,D - S}}\)

2 \({\text{A - S, B - P, C - Q, D - R}}\)

3 \({\text{A - P, B - R, C - S, D - Q}}\)

4 \({\text{A - S, B - Q, C - R, D - P}}\)

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347782 Early diagnosis of disease can be done by the technique

1 ELISA

2 PCR

3 Recombinant DNA technology

4 All the above

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347700 The first clinical gene therapy was done for the treatment of:

1 AIDS

2 Cancer

3 Cystic fibrosis

4 SCID (Severe Combined Immuno
Deficiency resulting from deficiency of ADA)

NCERTExemplar

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347699 The site of production of ADA in the body is

1 Blood plasma

2 Osteocytes

3 Lymphocytes

4 Erythrocytes

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347697 Assertion :
Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused.
Reason :
It affects the human digestive system.

1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.

2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.

3 Assertion is correct but Reason is incorrect.

4 Both Assertion and Reason are incorrect.

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347705 Match the following

Column I	Column II
A. Meloidogyne incognita	P. Controls corn borer
B. cryIAb	Q. Controls bollworm
C. cryIAc and cryIIAb	Q. Controls bollworm
D. ADA deficiency	R. Gene therapy
	S. Infects roots of tobacco plant

1 \({\text{A - Q,B - P,C - R,D - S}}\)

2 \({\text{A - S, B - P, C - Q, D - R}}\)

3 \({\text{A - P, B - R, C - S, D - Q}}\)

4 \({\text{A - S, B - Q, C - R, D - P}}\)

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347782 Early diagnosis of disease can be done by the technique

1 ELISA

2 PCR

3 Recombinant DNA technology

4 All the above

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347700 The first clinical gene therapy was done for the treatment of:

1 AIDS

2 Cancer

3 Cystic fibrosis

4 SCID (Severe Combined Immuno
Deficiency resulting from deficiency of ADA)

NCERTExemplar

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347699 The site of production of ADA in the body is

1 Blood plasma

2 Osteocytes

3 Lymphocytes

4 Erythrocytes

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347697 Assertion :
Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused.
Reason :
It affects the human digestive system.

1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.

2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.

3 Assertion is correct but Reason is incorrect.

4 Both Assertion and Reason are incorrect.

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347705 Match the following

Column I	Column II
A. Meloidogyne incognita	P. Controls corn borer
B. cryIAb	Q. Controls bollworm
C. cryIAc and cryIIAb	Q. Controls bollworm
D. ADA deficiency	R. Gene therapy
	S. Infects roots of tobacco plant

1 \({\text{A - Q,B - P,C - R,D - S}}\)

2 \({\text{A - S, B - P, C - Q, D - R}}\)

3 \({\text{A - P, B - R, C - S, D - Q}}\)

4 \({\text{A - S, B - Q, C - R, D - P}}\)

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347782 Early diagnosis of disease can be done by the technique

1 ELISA

2 PCR

3 Recombinant DNA technology

4 All the above

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347700 The first clinical gene therapy was done for the treatment of:

1 AIDS

2 Cancer

3 Cystic fibrosis

4 SCID (Severe Combined Immuno
Deficiency resulting from deficiency of ADA)

NCERTExemplar

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347699 The site of production of ADA in the body is

1 Blood plasma

2 Osteocytes

3 Lymphocytes

4 Erythrocytes

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347697 Assertion :
Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused.
Reason :
It affects the human digestive system.

1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.

2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.

3 Assertion is correct but Reason is incorrect.

4 Both Assertion and Reason are incorrect.

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347705 Match the following

Column I	Column II
A. Meloidogyne incognita	P. Controls corn borer
B. cryIAb	Q. Controls bollworm
C. cryIAc and cryIIAb	Q. Controls bollworm
D. ADA deficiency	R. Gene therapy
	S. Infects roots of tobacco plant

1 \({\text{A - Q,B - P,C - R,D - S}}\)

2 \({\text{A - S, B - P, C - Q, D - R}}\)

3 \({\text{A - P, B - R, C - S, D - Q}}\)

4 \({\text{A - S, B - Q, C - R, D - P}}\)

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347782 Early diagnosis of disease can be done by the technique

1 ELISA

2 PCR

3 Recombinant DNA technology

4 All the above

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347700 The first clinical gene therapy was done for the treatment of:

1 AIDS

2 Cancer

3 Cystic fibrosis

4 SCID (Severe Combined Immuno
Deficiency resulting from deficiency of ADA)

NCERTExemplar

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347699 The site of production of ADA in the body is

1 Blood plasma

2 Osteocytes

3 Lymphocytes

4 Erythrocytes

BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS

347697 Assertion :
Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused.
Reason :
It affects the human digestive system.

1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.

2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.

3 Assertion is correct but Reason is incorrect.

4 Both Assertion and Reason are incorrect.

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Question Bank Series

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation:

Explanation: